Pharmacology

Journal of Pediatric Gastroenterology and Nutrition

Volumn 47, Issue 5, 2008, Pages 703-705

  Lebel, Alyssa A ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CARBAMAZEPINE; CITALOPRAM; CYPROHEPTADINE; DULOXETINE; ETIRACETAM; FAMOTIDINE; GABAPENTIN; LAMOTRIGINE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PHENYTOIN; PIZOTIFEN; PLACEBO; PREGABALIN; PROPRANOLOL; SEDATIVE AGENT; SEROTONIN 3 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SOMATOSTATIN DERIVATIVE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE; ZONISAMIDE; HYPNOTIC SEDATIVE AGENT;

ABDOMINAL MIGRAINE; ABDOMINAL PAIN; BEHAVIOR THERAPY; BRAIN; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; CONFERENCE PAPER; DEPRESSION; DIABETIC NEUROPATHY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; FIBROMYALGIA; FUNCTIONAL ABDOMINAL PAIN; FUNCTIONAL DYSPEPSIA; GASTROINTESTINAL TRANSIT; HEADACHE; HEART ARRHYTHMIA; HUMAN; HYPERALGESIA; INTESTINE; IRRITABLE COLON; MIGRAINE; MOOD DISORDER; NERVE INJURY PAIN; NEURALGIA; NEUROPATHIC PAIN; NOCICEPTION; PAIN; PAIN ASSESSMENT; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; SEIZURE; SENSORY NERVE; SPINAL CORD; SUICIDE; THERMAL STIMULATION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; ARTICLE; CHILD; DRUG EFFECT; GASTROINTESTINAL DISEASE; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT;

AFFERENT PATHWAYS; ANALGESICS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; CHILD; GASTROINTESTINAL DISEASES; HUMANS; HYPNOTICS AND SEDATIVES; IRRITABLE BOWEL SYNDROME; PAIN;

EID: 59849104324     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000338966.70550.d1     Document Type: Conference Paper

References (24)

1. Craig AD. How do you feel? Interoception: the sense of the physiologic condition of the body. Nat Rev Neurosci 2002;3: 655-66.
2. Porreca F, Ossipov MH, Gebhart GF. Chronic pain and medullary descending facilitation. Trends Neurosci 2002; 25: 319-25.
3. Weydert JA. Systematic review of treatments for recurrent abdominal pain. Pediatrics 2003;111:e1-1.
4. Huertas-Ceballos A, McArthur C, Logan S, Pharmacologic interventions for recurrent abdominal pain. Cochrane Database Syst Rev 2002; CD003017.
5. See MC, Birnbaum AH, Schecter CB, et al. Double-blind, placebo-controlled trial of famotidine in children wit abdominal pain and dyspepsia. Dig Dis Sci 2001;46:985-92.
6. Symon DN, Russell G. Double-blind placebo-controlled trial of pizotifen syrup in the treatment of abdominal migraines. Arch Dis Child 1995;72:48-50.
7. Faure C. Somatic referral of visceral sensations and rectal sensory threshold for pain in children with functional gastrointestinal disorders. J Pediatr 2007;150:66-71.
8. Mayer EA, Tillisch K, Bradesi S. Modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 2006;24:919-33.
9. Martinez JA, Bueno L. Buspirone inhibits corticotrophin-re-leasing factor and stress-induced cecal motor response in ratsby acting through 5-HT1A receptors. Eur J Pharmacol 1991;202: 379-83.
10. Tack J, Piessevaux H, Coulie B, et al. A placebo-controled trial of buspirone, a fundus-relaxing drug, in functional dyspepsia: effect on symptoms and gastric sensory and motor function. Gastroenterology 1991;116:A325.
11. Chial HJ, Camilleri M, Ferber I, et al. Effects of venlafaxine, buspirone, and placebo on colonic snsorimotor functions in healthy humans. Clin Gastroenterol Hepatol 2003;1:211-8.
12. Olden KW. The use of antidepressnts in functional gastrointestinal disorders: new uses for old drugs. CNS Spectr 2005;10: 891-7.
13. Jackson JL, O'Malley PG, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000;108:65-72.
14. Tack J, Muller-Lissner S, Bytzer P, et al. A randomized controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation. Gut 2005;54:1707-13.
15. Campo JV, Perel J, Lucas A, et al. Citalopram treatment of pediatric recurrent abdominal pain and comorbid internalizing disorders: an exploratory study. J Child Adoles Psychiatry 2004;43:1234-42.
16. Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain 2005;119:5-15.
17. Raskin J, Pritchett YL, Wang F, et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med 2005;6: 346-56.
18. Levinstein B. A comparative staudy of cyproheptadine, amitripty-line, and propranolol in the treatment of adolescent migraine. Cephalagia 1991;11:122-3.
19. Hershey AD, Powers SW, Benitti AL, et al. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000;40:539-49.
20. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicidal attempts in pediatric anti-depressant treatment. JAMA 2007;297:1683-96.
21. Bradette M, Moennikes H, Carter F, et al. Cilansetron in irritable bowel syndrome with diarrhea predominance: efficacy and safety in a 6 month global study. Gastroenterology 2004;126: A-42.
22. Friedel D, Thomas R, Fisher RS. Ischemic colitis during treatment with alosteron. Gastroenterology 2001;120:557-60.
23. Talley NJ. 5-Hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications. Aliment Pharmacol Ther 1992;6:273-89.
24. Klooker TK, Beaumont H, Kuilen SD, et al. Octreatide as potential treatment for patients with non-constipated irritable bowel syndrome. Gastroenterology 2005;128:A-93-4.